Angle closure and angle-closure glaucoma: What we are doing now and what we will be doing in the future

David S. Friedman, Paul J. Foster, Tin Aung, Mingguang He

Research output: Contribution to journalReview article

Abstract

Primary angle-closure glaucoma (PACG) frequently leads to severe vision loss. Prevalence among older Asian populations is high and given global demographics, the number of persons with PACG will increase dramatically in the coming decades. Improvements in imaging of the anterior segment will help us to identify more of those with angle closure, and important clinical trials that are currently underway will provide important evidence to support screening and treatment approaches for PACG. In this manuscript, we intend to review the existing evidences, to introduce some important on-going studies on PACG and to share the experience and viewpoints of the authors.

Original languageEnglish (US)
Pages (from-to)381-387
Number of pages7
JournalClinical and Experimental Ophthalmology
Volume40
Issue number4
DOIs
StatePublished - May 1 2012

Keywords

  • Angle-closure glaucoma
  • Clinical trial
  • Epidemiology

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Angle closure and angle-closure glaucoma: What we are doing now and what we will be doing in the future'. Together they form a unique fingerprint.

  • Cite this